Bayer AG (BAYN.DE) stock analysis

In our weekly check, Bayer AG is graded D (A to F). Of 23 checks on debt, profit, cash flow and trend: 9 pass, warnings: 7, red flags: 7.

About Bayer AG

Bayer AG is a Healthcare company (Drug Manufacturers - General) based in Germany, listed on XETRA as BAYN.DE.

What our checks show for BAYN.DE

Red flags

Warning signs

Strengths

Next earnings report: 2026-11-03

Similar companies

BIIB · 1093.HK · SNY · GSK · BMY · ORNBV.HE

Questions

What grade does Bayer AG (BAYN.DE) have?

In our weekly check, Bayer AG is graded D (A to F). Of 23 checks on debt, profit, cash flow and trend: 9 pass, warnings: 7, red flags: 7. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of BAYN.DE stock?

This week's biggest flags for Bayer AG: High debt, Margins falling, Weak revenue growth. In total 14 of 23 checks show a warning or a red flag.

What does Bayer AG do?

Bayer AG is a Healthcare company (Drug Manufacturers - General) based in Germany, listed on XETRA as BAYN.DE.

When does Bayer AG report earnings next?

The next earnings report is expected on 2026-11-03. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-24

Open the full analysis